Acro Biomedical (ACBM) Other financing activities (2017 - 2025)

Acro Biomedical (ACBM) recorded quarterly Other financing activities of $2315.0 in Q4 2025, up 203.81% quarter-over-quarter from $762.0 in Q4 2019.

Acro Biomedical (ACBM) Other financing activities (2017 - 2025) Analysis & Trends

Acro Biomedical's Other financing activities history runs 3 years deep, the most recent figure standing at $2315.0 for Q4 2025.

In Q4 2025, Other financing activities changed N/A year-over-year to $2315.0; the TTM figure through Dec 2025 stood at $3077.0 (up 303.81% YoY), while the FY2025 annual figure was $4600.0, changed N/A from the prior year.
Other financing activities was $2315.0 for Q4 2025 at Acro Biomedical, up from $762.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $2315.0 in Q4 2025 to a low of $2315.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	EQV Ventures Acquisition	477.93 Mn	477.93 Mn	-
2	GP-Act III Acquisition	312.80 Mn	312.80 Mn	-
3	Berto Acquisition	311.56 Mn	311.56 Mn	-
4	Churchill Capital Corp IX	310.79 Mn	310.79 Mn	-
5	Centurion Acquisition	310.21 Mn	310.21 Mn	-
6	WEN Acquisition	309.15 Mn	309.15 Mn	-
7	Agriculture & Natural Solutions Acquisition	303.81 Mn	303.81 Mn	-
8	Bold Eagle Acquisition	274.64 Mn	274.64 Mn	-
9	Live Oak Acquisition Corp. V	265.88 Mn	265.88 Mn	-
10	Acro Biomedical	-	-	-

Download Data